Ignite Creation Date:
2025-12-24 @ 4:31 PM
Ignite Modification Date:
2026-02-27 @ 5:09 PM
Study NCT ID:
NCT02950766
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-05
First Post:
2016-09-08
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
NeoVax Plus Ipilimumab in Renal Cell Carcinoma
Sponsor:
Patrick Ott, MD, PhD
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
16-097
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None